MAIA Biotechnology, Inc.
MAIA
$1.32
$0.021.15%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.41M | 8.66M | 10.89M | 10.14M | 10.86M |
| Total Receivables | -- | -- | 82.70K | 82.30K | 78.10K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 902.00K | 1.04M | 780.50K | 816.30K | 920.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 35.32M | 9.70M | 11.75M | 11.04M | 11.86M |
|
|
|||||
| Total Current Assets | 35.32M | 9.70M | 11.75M | 11.04M | 11.86M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.50K | 2.80K | 27.10K | 2.80K | 2.80K |
| Total Assets | 35.32M | 9.70M | 11.78M | 11.05M | 11.86M |
|
|
|||||
| Total Accounts Payable | 2.98M | 2.04M | 3.18M | 1.72M | 1.84M |
| Total Accrued Expenses | 3.34M | 3.80M | 4.70M | 3.32M | 3.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 2.12M | -- | -- |
| Total Other Current Liabilities | -- | -- | 2.12M | -- | -- |
| Total Current Liabilities | 6.32M | 5.84M | 9.99M | 5.04M | 5.06M |
|
|
|||||
| Total Current Liabilities | 6.32M | 5.84M | 9.99M | 5.04M | 5.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.24M | 1.49M | 1.75M | 2.13M | 1.86M |
| Total Liabilities | 7.56M | 7.33M | 11.74M | 7.17M | 6.92M |
|
|
|||||
| Common Stock & APIC | 143.80M | 112.06M | 106.07M | 101.01M | 96.73M |
| Retained Earnings | -116.00M | -109.63M | -106.00M | -97.10M | -91.75M |
| Treasury Stock & Other | -39.70K | -50.20K | -30.80K | -30.00K | -38.20K |
| Total Common Equity | 27.76M | 2.38M | 41.70K | 3.88M | 4.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 27.76M | 2.38M | 41.70K | 3.88M | 4.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 27.76M | 2.38M | 41.70K | 3.88M | 4.94M |
|
|
|||||